Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7056015 | 1.00 | KCNH2 (0.38) | KCNH2TYRMEN1TP53CYP3A4 | |
| SCHEMBL7530621 | 1.00 | KCNH2 (0.38) | KCNH2TYRMEN1TP53CYP3A4 | |
| SCHEMBL7717379 | 0.98 | KCNH2 (0.37) | KCNH2TYRMEN1TP53CYP3A4 | |
| SCHEMBL7572175 | 0.98 | KCNH2 (0.35) | KCNH2TYRMEN1TP53CYP3A4 | |
| SCHEMBL4522301 | 0.88 | SPHK2 (0.33) | TYRMEN1TP53CYP3A4ALOX5 | |
| SCHEMBL7533536 | 0.85 | LIPG (0.34) | KCNH2CYP3A4MAPTTSHRLIPG | |
| SCHEMBL7595832 | 0.82 | MAPK14 (0.40) | CYP3A4MAPTTSHR | |
| SCHEMBL10595842 | 0.82 | CYSLTR2 (0.44) | MEN1KMT2ATLR8 | |
| SCHEMBL7592687 | 0.80 | GCGR (0.41) | MAPTTLR8 | |
| SCHEMBL7580698 | 0.80 | MAPK13 (0.39) | CYP3A4MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002096913-A1 | SUBSTITUTED DI(HYDROXY/ALKOXY)SILICON PHTHALOCYANINES AND THEIR USES | GENTIAN AS (NO) | 2002-12-05 | — | — | WO | disclosed |
| US-20020128249-A1 | Phthalocyanine analogs | QINETIQ | 2002-09-12 | — | — | US | disclosed |
| US-6384027-B1 | METALLIZED PHTHALOCYANINE DYES | QINETIQ LIMITED (GB) | 2002-05-07 | — | — | US | disclosed |
| EP-1027354-A1 | PHTHALOCYANINE ANALOGS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999023096-A1 | PHTHALOCYANINE ANALOGS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1999-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128249-A1 | Phthalocyanine analogs | CBR1, NPY1R, CYC1 | KCNH2 373/4885TYR 731/4885MEN1 978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.